Skip to main content
. 2020 Feb 10;45(4):1059–1072. doi: 10.3892/ijmm.2020.4496

Figure 9.

Figure 9

Schematic diagram of the anti-tumor function of scutellarein in colon cancer. Scutellarein treatment reduced the expression of RAGE via the CDC4-mediated ubiquitination degradation pathway, which then inhibited cell proliferation, tumorigenesis and induced cell apoptosis in colon cancer. RAGE, receptor for advanced glycation end products; CDC4, cell division control protein 4.